Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation

Clinical trial NCT03867851 · TERMINATED

Trial details

NCT number: NCT03867851
Sponsor: TikoMed AB
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2021-02-08
Primary completion: 2024-05-13
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.